Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06967337 · ClinicalTrials.gov registry record · NA
Microsteps Study-Short, Animated Storytelling Video
A NA study of Behavior, Health, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 5,431
- Enrollment target
- 1
- Study location
NCT06967337: Completed NA study of Behavior, Health, sponsored by Stanford University.
NCT06967337 is a NA study of Behavior, Health that has completed, run by Stanford University. The registered enrollment target is 5,431 participants, below the 15,520-participant average among 20 other Behavior, Health trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06967337, a NA study of Behavior, Health, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,431 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the effect of single exposure to written Microsteps messages and short video booster content, on behavioral expectation to adopt behavioral nudges, in the immediate and medium term. Beyond that, the study will examine the effect of exposure to written Microsteps messages and short video booster content, on hope and happiness. This study will be conducted entirely online. Adult participants, in the US and the UK, will be recruited through the platform Prolific Academic (ProA).
Primary Outcome
This measure is intended to explore the effect of the written messages, with two different approaches to the video booster, on behavioral expectation to adopt the Microsteps, in the immediate and medium-term. The Microsteps questionnaire consists of 8 questions, each measured on a Likert scale from 1-5 where 1 = very unlikely and 5 = very likely.
Conditions Studied
Interventions
- BEHAVIORAL Microsteps
- BEHAVIORAL Storytelling video
- BEHAVIORAL Instructional Video
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,431 participants |
| Start Date | 2025-06-19 |
| Est. Completion | 2025-07-21 |
| Phase | NA |
What the finished NCT06967337 record still lists
NCT06967337 is an interventional study that assigns participants to a tested intervention. Its 5,431 participants enrollment target places it among the larger protocols in the corpus, below the 15,520-participant average among 20 other Behavior, Health trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Behavior, Health appearing as the primary indexed condition, and to 3 interventions - of which Microsteps is the first listed.
NCT06967337 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06967337 about?
NCT06967337 is a clinical study titled "Microsteps Study-Short, Animated Storytelling Video". This study evaluates the effect of single exposure to written Microsteps messages and short video booster content, on behavioral expectation to adopt behavioral nudges, in the immediate and medium term. Beyond that, the study will examine the effect of exposure to written Microsteps messages and sho...
What is the current status of trial NCT06967337?
This trial is currently completed. It is a NA study. The enrollment target is 5,431 participants. The study started on 2025-06-19. Estimated completion is 2025-07-21.
What conditions does trial NCT06967337 study?
This clinical trial studies the following conditions: Behavior, Health.
What interventions are being tested in trial NCT06967337?
The interventions under investigation include: Microsteps (BEHAVIORAL), Storytelling video (BEHAVIORAL), Instructional Video (BEHAVIORAL).
Who is sponsoring clinical trial NCT06967337?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06967337 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Behavior, Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06967337's enrollment target sits among peer trials
5,431 4th of 20 higher than 17 of 20 other Behavior, Health trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Behavior, Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Fit With Us Study
RECRUITING · NA
-
Parent-Child Memory Study: Improving Future Thinking Among Mothers
RECRUITING · NA
-
Healthy for Two-Home Visiting (H42-HV): Health Coaching for Pregnant Women
RECRUITING · NA
-
Game-based Pediatric Diabetes Education
RECRUITING · NA
-
Personalized Health Self-Management Training for Colorectal Cancer Survivors
RECRUITING · NA
-
Improving Congenital Heart Disease Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722769 · 5,408 participants · NA
CSTOP Now! Child Sex Trafficking Stops With You
- NCT04295486 · 5,478 participants · Phase 2
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
- NCT05952557 · 5,500 participants · Phase 3
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
- NCT06084234 · 5,500 participants · Phase 4
National Liver Cancer Screening Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI